Zhitong Finance App News, Baixinan-B (02185.HK) announced that the company recently signed a strategic cooperation agreement (strategic cooperation agreement) with Shanghai Shenqi Medical Technology Co., Ltd. (Shenqi Medical) to jointly promote the commercialization and clinical application of the Bioheart® bioabsorbable rapamycin-eluting coronary stent system (BioHeart stent, a product developed independently by the company).

Zhitongcaijing · 2d ago
Zhitong Finance App News, Baixinan-B (02185.HK) announced that the company recently signed a strategic cooperation agreement (strategic cooperation agreement) with Shanghai Shenqi Medical Technology Co., Ltd. (Shenqi Medical) to jointly promote the commercialization and clinical application of the Bioheart® bioabsorbable rapamycin-eluting coronary stent system (BioHeart stent, a product developed independently by the company).